T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review

Journal of Autoimmunity
Iria Gomez-TourinoM Peakman

Abstract

Type 1 diabetes was one of the earliest disorders to be associated with the phenomenon of autoimmunity and is one of the most studied organ-specific autoimmune diseases at the epidemiologic, immunologic and genetic level. Despite this, and the emergence of a plethora of strategies for trying to intervene in, or prevent the disease, it remains at some distance from being reliably and safely tractable by immunotherapy, a source of great frustration in this research field. In this article we review some of the key concepts that might impact upon this lack of success in the clinic going forward. These include new insights into autoreactive CD4 and CD8 T cell biology and a discussion of the concept of disease heterogeneity as it applies to type 1 diabetes. The onset of disease is characterised by a delicate equilibrium of proinflammatory and regulatory T cells, which we have termed "balanced autoreactive set-point", and which may be amenable to antigen-specific immunotherapies that alter the rate of disease progression. Advances in the characterization of T cells, especially at the single cell level, could be rewarding, notably from the vantage point of biomarker and surrogate discovery. A better understanding of T cell targeting, a...Continue Reading

References

May 26, 1995·Science·J D KatzD Mathis
Jun 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·H McDevittR Tisch
Jul 3, 2002·Endocrinology and Metabolism Clinics of North America·Edwin Liu, George S Eisenbarth
Feb 3, 2004·The Journal of Clinical Investigation·Sefina ArifMark Peakman
Jun 9, 2004·The Journal of Experimental Medicine·Qizhi TangJeffrey A Bluestone
Apr 7, 2005·Nature Medicine·Mark Larché, David C Wraith
Nov 2, 2005·The Journal of Experimental Medicine·Stuart I ManneringAnthony W Purcell
Nov 11, 2008·Nature Medicine·Angel Varela-RohenaJames L Riley
Nov 29, 2008·Clinical and Experimental Immunology·J M LawsonT I M Tree
Dec 2, 2008·Clinical and Experimental Immunology·S L ThrowerM Peakman
Jan 9, 2009·Clinical and Experimental Immunology·A WillcoxN G Morgan
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jan PetersenAnthony W Purcell
May 16, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Kevan C HeroldUNKNOWN Immune Tolerance Network ITN007AI Study Group
Jan 12, 2010·Clinical and Experimental Immunology·B O RoepF Dotta
Feb 9, 2010·Nature Immunology·Brian D StadinskiKathryn Haskins
May 29, 2010·Diabetes Care·Mikael KnipHans K Akerblom
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Brian D StadinskiJohn W Kappler
Sep 2, 2010·Diabetes·Mark Peakman, Matthias von Herrath
Sep 21, 2010·Current Opinion in Immunology·Catherine A Sabatos-PeytonDavid C Wraith
Jul 26, 2011·Clinical & Developmental Immunology·Roberto MalloneChristian Boitard
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Frances CrawfordJohn W Kappler
Oct 18, 2011·European Journal of Immunology·Ian GaleaStephen M Thirdborough
Nov 15, 2011·Nature Reviews. Immunology·Jacques NeefjesOddmund Bakke

❮ Previous
Next ❯

Citations

Mar 1, 2016·Frontiers in Immunology·Aline IgnacioRafael Ribeiro Almeida
Feb 24, 2016·Autoimmunity Reviews·George J Kahaly, Martin P Hansen
Jul 10, 2016·Autoimmunity Reviews·Ulrich SackStephan Fricke
Jan 31, 2016·Journal of Immunological Methods·Sarah M TheakerGarry Dolton
Jan 14, 2017·Archivum Immunologiae Et Therapiae Experimentalis·Rubén Varela-CalvinoOscar J Cordero
Mar 21, 2017·Cellular & Molecular Immunology·Ying ZhengZhiguang Zhou
May 12, 2018·Diabetes, Obesity & Metabolism·Francois CurtinUNKNOWN RAINBOW-T1D investigators
Sep 14, 2018·Diabetologia·Chantal MathieuTimothy Tree
Jun 11, 2019·The New England Journal of Medicine·Clifford J Rosen, Julie R Ingelfinger
Jun 23, 2016·American Journal of Physiology. Endocrinology and Metabolism·María S BianchiVictoria A Lux-Lantos
Sep 29, 2019·International Journal of Molecular Sciences·Miriam Cabello-OlmoMiguel Barajas
Apr 26, 2017·Frontiers in Immunology·Ankit SaxenaAbdel Rahim A Hamad
Jul 4, 2020·Nature Reviews. Materials·C L StablerB G Keselowsky
Jul 25, 2017·Archivum Immunologiae Et Therapiae Experimentalis·Bhagirath SinghKelly L Summers
Sep 1, 2018·Frontiers in Immunology·Charles J KrogerRoland M Tisch
Jun 27, 2019·Scientific Reports·Tania SinghIsabella Artner
Jan 15, 2021·Glycobiology·Tristan J de JesusParameswaran Ramakrishnan
Feb 20, 2021·Frontiers in Immunology·Matthew ClarkRoland M Tisch
Mar 9, 2021·Frontiers in Immunology·Qi KeRoland M Tisch
Mar 12, 2021·Journal of Autoimmunity·Mehdi A BenkahlaMatthias G von Herrath
Jun 29, 2021·Endocrine Reviews·Steven E KahnC Bruce Verchere
Aug 28, 2021·International Journal of Molecular Sciences·Laura PasseriSilvia Gregori

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

© 2021 Meta ULC. All rights reserved